SOLARA ACTIVE PHARMA SCIENCES
Back to Balance Sheet
|
SOLARA ACTIVE PHARMA SCIENCES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹60 Cr | ₹60 Cr | ₹3.61 Cr | ₹3.22 Cr | ₹6.22 Cr |
What is the latest Contingent Liabilities ratio of SOLARA ACTIVE PHARMA SCIENCES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹60 Cr |
| Mar2024 | ₹60 Cr |
| Mar2023 | ₹3.61 Cr |
| Mar2022 | ₹3.22 Cr |
| Mar2021 | ₹6.22 Cr |
How is Contingent Liabilities of SOLARA ACTIVE PHARMA SCIENCES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹60 Cr | -0.30 | |
| Mar2024 | ₹60 Cr | 1,563.71 | |
| Mar2023 | ₹3.61 Cr | 12.11 | |
| Mar2022 | ₹3.22 Cr | -48.23 | |
| Mar2021 | ₹6.22 Cr | - | |
Compare Contingent Liabilities of peers of SOLARA ACTIVE PHARMA SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOLARA ACTIVE PHARMA SCIENCES | ₹2,720.9 Cr | -1.1% | -4.3% | -19.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,037.0 Cr | -3% | -3.6% | -4.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,795.0 Cr | -3.1% | 0.1% | 11.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,332.0 Cr | -3.7% | 4% | 18.8% | Stock Analytics | |
| CIPLA | ₹116,933.0 Cr | -1.3% | -4.6% | -1.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,350.2 Cr | -4.2% | -7% | -11.4% | Stock Analytics | |
SOLARA ACTIVE PHARMA SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOLARA ACTIVE PHARMA SCIENCES | -1.1% |
-4.3% |
-19.3% |
| SENSEX | -1.7% |
-1.4% |
7% |
You may also like the below Video Courses